Nature10 个月
Pfizer stakes a claim in plant cell–made biopharmaceuticals
It acquired rights to taligurase alfa, a form of the enzyme glucocerebrosidase in development for the treatment of Gaucher's disease, from Protalix Biotherapeutics in Carmiel, Israel. Protalix has ...
Health and Me on MSN8 天
Explained: Gaucher's Disease - The Rare Condition You’ve Never Heard Of—But Should
As per the National Gaucher Foundation, this disease was first discovered by a French doctor, Philippe Gaucher, after whom it ...
来自MSN1 个月
Vanqua’s Parkinson’s drug shows promise as company initiates Phase Ib study
VQ-101 is an oral, small molecule allosteric activator targeting the lysosomal enzyme glucocerebrosidase (GCase) that is undergoing evaluation as a potential treatment for Parkinson’s disease in ...